Physician profile
Jo M Kim
NPI 1205092921
$3,820.33
in general payments reported to CMS, 2019-2025
21 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $651 · 2020: $412 · 2021: $803 · 2022: $918 · 2023: $540 · 2024: $327 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,466.33 | 2019-2024 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $566.51 | 2019-2023 | Evenity, Prolia |
| Novo Nordisk INC | $485.91 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $341.71 | 2019-2024 | |
| Pfizer INC. | $201.18 | 2021-2023 | |
| Amarin Pharma, INC. | $163.38 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $153.17 | 2019-2021 | |
| Ibsa Pharma INC. | $76.01 | 2021-2025 | Licart, Tirosint, Flector |
| Vivus LLC | $50.12 | 2021 | |
| Gilead Sciences, INC. | $49.30 | 2020-2021 | |
| Glaxosmithkline, LLC. | $42.28 | 2022 | |
| Nestle Healthcare Nutrition INC. | $39.03 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $36.43 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $35.46 | 2024-2025 | |
| Daiichi Sankyo INC. | $19.54 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.35 | 2023 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $16.35 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $16.06 | 2022 | |
| Aimmune Therapeutics, INC. | $15.41 | 2024 | |
| Exact Sciences Corporation | $13.68 | 2025 | Cologuard Collection Kit |
| Qiagen, LLC | $13.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jo Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.